Aurinvest

Aurinvest is a Paris-based venture capital firm established in 2011, primarily funded and managed by over fifty entrepreneurs, business leaders, and institutional investors. The firm focuses on investing in high-growth companies, particularly within the information technology and life sciences sectors in France. Aurinvest aims to support founders in realizing their business objectives by providing guidance and expertise. Each investment is backed by two seasoned professionals who maintain close relationships with the company's management, facilitating access to Aurinvest's extensive network to enhance the growth potential of its portfolio companies.

Geoffroy Bragadir

CEO and Management Committee Member

Jean-Claude Gofard

Partner

Patrick Pollet

Partner

32 past transactions

PathoQuest

Series B in 2021
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.

PathoQuest

Venture Round in 2018
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.

Evercontact

Convertible Note in 2018
Evercontact is an email software startup specializing in contact management through the use of natural language processing. Launched in 2014 by a team of skilled developers and linguistic engineers, the platform automatically updates users' contacts by extracting relevant information from email correspondence. In August 2016, Evercontact was acquired by One More Company Inc, enhancing its capabilities in the realm of automated contact management.

Famoco

Series B in 2017
Famoco SAS, founded in 2010 and headquartered in Paris, France, specializes in providing mobile, Android-based NFC readers aimed at enhancing contactless transactions for businesses. The company develops secure, corporate-owned devices with zero-street-value, designed for privacy and remotely manageable through a single software platform. Famoco’s ecosystem allows organizations to deploy business applications efficiently while ensuring secure data capture for various functions, including mobile payments, public transport, identity verification, and workforce management. Clients can configure device profiles, push applications, and monitor device locations through Famoco's management suite. With operations extending to Schaerbeek, Belgium, and Hong Kong, the company has successfully deployed over 250,000 devices across more than 35 countries, supporting businesses in their digital transformation efforts.

OpenDataSoft

Series A in 2016
OpenDataSoft provides a comprehensive data-sharing platform that enables organizations to publish, manage, visualize, and share their data effectively. The company's software-as-a-service (SaaS) solution serves as a centralized hub, allowing users to access and analyze data in various formats. By facilitating data publishing and application programming interface management, OpenDataSoft empowers teams to create engaging digital experiences and fosters collaboration through data reuse. The platform aims to accelerate digital transformation, enhance operational efficiency, and help organizations derive value from their data by promoting a culture of sharing and accessibility.

Bizmeeting

Seed Round in 2016
Bizmeeting, SAS is an online platform based in Roubaix, France, that specializes in providing rental accommodations for seminars, training sessions, and professional meetings. Founded in 2014, the company offers a comprehensive booking service that features approximately 20,000 venues across France, including hotels, business centers, conference facilities, and unique locations like museums. Bizmeeting has developed two distinct products: a public-facing website for general customers and a dedicated booking platform tailored for recurring clients. This platform not only facilitates the booking of various spaces for events such as workshops, trade shows, and conventions but also helps clients centralize their event planning and manage associated costs effectively.

One More Company

Seed Round in 2016
One More Company, Inc. specializes in contextual intelligence email services, with its flagship product, Senders™, designed to enhance the email experience for users. Senders™ functions similarly to Caller ID for email, providing recipients with additional information about the sender, thus improving communication across various apps, platforms, and devices. The company, which also developed Trackbuster™, prioritizes user privacy and data security, adopting a "privacy by design" approach throughout its product development. One More Company operates under a business model that emphasizes consumer control and transparency, avoiding reliance on advertising or data monetization. Founded by experienced executives from prominent tech companies, One More Company has offices in New York and Paris and is dedicated to delivering simple, intuitive messaging solutions that prioritize the interests of its users.

Captain Contrat

Seed Round in 2016
Captain Contrat SAS operates an online service which provides legal documents to lawyers. The company was founded in 2013 and is based in Paris, France.

Jabmo

Series B in 2015
Jabmo pioneered a whole new approach to account-based marketing with their hyper-aware ABM platform, advertising, and managed services. They are the disruptive vendor in a market where most B2B marketing programs still focus only on known contacts. Their vision, technology, and talent have fueled their rapid growth worldwide. Global manufacturers such as Eaton and BD rely on Jabmo to drive revenue by serving personalized and relevant ads to target accounts throughout the buying cycle. They are specialized in ABM for manufacturers and they are the most international vendor with local support throughout EMEA and USA. With their ABM Platform, their customers see over 2X marketing engagement from target accounts and higher sales win rates.

PathoQuest

Venture Round in 2015
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.

Famoco

Series A in 2015
Famoco SAS, founded in 2010 and headquartered in Paris, France, specializes in providing mobile, Android-based NFC readers aimed at enhancing contactless transactions for businesses. The company develops secure, corporate-owned devices with zero-street-value, designed for privacy and remotely manageable through a single software platform. Famoco’s ecosystem allows organizations to deploy business applications efficiently while ensuring secure data capture for various functions, including mobile payments, public transport, identity verification, and workforce management. Clients can configure device profiles, push applications, and monitor device locations through Famoco's management suite. With operations extending to Schaerbeek, Belgium, and Hong Kong, the company has successfully deployed over 250,000 devices across more than 35 countries, supporting businesses in their digital transformation efforts.

OpenDataSoft

Seed Round in 2015
OpenDataSoft provides a comprehensive data-sharing platform that enables organizations to publish, manage, visualize, and share their data effectively. The company's software-as-a-service (SaaS) solution serves as a centralized hub, allowing users to access and analyze data in various formats. By facilitating data publishing and application programming interface management, OpenDataSoft empowers teams to create engaging digital experiences and fosters collaboration through data reuse. The platform aims to accelerate digital transformation, enhance operational efficiency, and help organizations derive value from their data by promoting a culture of sharing and accessibility.

Smallable

Series B in 2015
Smallable SAS is an online retailer based in Paris, France, specializing in a diverse range of products for children and families. Founded in 2008, the company offers over 30,000 items, including designer clothing, shoes, and fashion accessories for children, as well as furniture and decoration products such as cribs, chairs, and decorative items. Smallable features a selection of toys and books, encompassing everything from plush toys and creative games to educational books. The company is distinguished by its extensive collection of over 800 designer brands, including notable names like Bobo Choses and Stella McCartney. Additionally, Smallable provides gift options and gift certificates, catering to various occasions and preferences, ensuring a comprehensive shopping experience for families.

Evercontact

Convertible Note in 2015
Evercontact is an email software startup specializing in contact management through the use of natural language processing. Launched in 2014 by a team of skilled developers and linguistic engineers, the platform automatically updates users' contacts by extracting relevant information from email correspondence. In August 2016, Evercontact was acquired by One More Company Inc, enhancing its capabilities in the realm of automated contact management.

Jabmo

Series A in 2015
Jabmo pioneered a whole new approach to account-based marketing with their hyper-aware ABM platform, advertising, and managed services. They are the disruptive vendor in a market where most B2B marketing programs still focus only on known contacts. Their vision, technology, and talent have fueled their rapid growth worldwide. Global manufacturers such as Eaton and BD rely on Jabmo to drive revenue by serving personalized and relevant ads to target accounts throughout the buying cycle. They are specialized in ABM for manufacturers and they are the most international vendor with local support throughout EMEA and USA. With their ABM Platform, their customers see over 2X marketing engagement from target accounts and higher sales win rates.

Mobeye

Series A in 2015
Mobeye S.A.S. develops an iPhone and Android based application that allows users to earn money when taking pictures in stores near them. Its application enables users to answer short questionnaires, collect prices, and take pictures while shopping. The company was incorporated in 2013 and is based in Paris, France.

TeVolution

Series A in 2014
TeVolution offers a full television bundle (OTT): movies, series, entertainment and digital testrial television (TNT). TeVolution, a French television operator with an enhanced offer for all types of broadband, has established itself in the connected TV market by offering a unique and innovative offer

Beevibes

Series A in 2014
Beevibes has developed a service that recommends branded content to Internet users. We offer advertisers an engaging new way to deliver impacting brand campaigns on a premium publisher network. Our semantic targeting tech, combined with an exclusive in-content format delivers above standard visibility and engagement results.

Famoco

Venture Round in 2013
Famoco SAS, founded in 2010 and headquartered in Paris, France, specializes in providing mobile, Android-based NFC readers aimed at enhancing contactless transactions for businesses. The company develops secure, corporate-owned devices with zero-street-value, designed for privacy and remotely manageable through a single software platform. Famoco’s ecosystem allows organizations to deploy business applications efficiently while ensuring secure data capture for various functions, including mobile payments, public transport, identity verification, and workforce management. Clients can configure device profiles, push applications, and monitor device locations through Famoco's management suite. With operations extending to Schaerbeek, Belgium, and Hong Kong, the company has successfully deployed over 250,000 devices across more than 35 countries, supporting businesses in their digital transformation efforts.

Pixeo

Series B in 2013
Pixeo is an online and offline price comparison service dedicated to insurance.

PathoQuest

Series B in 2013
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.

MerciHenri.com

Venture Round in 2013
MerciHenri.com, which has served over 3 million customers since its inception in 2011, is the only insurance comparison website within the French market whose offering extends beyond price comparisons. It enables customers to filter their search criteria according to their budget and desired level of protection and services, as well as the availability of insurance agents or brokers to provide individually tailored assistance locally. Its website, which receives around 1 million unique visits every month, offers an immediate comparison of more than 80 insurers and lists more than 1,500 insurance brokers, agents and local advisors.

Adamence

Series B in 2011
Adamence, established in 2005 and based in Palaiseau, France, is an online jewelry retailer that specializes in a diverse range of premium jewelry. The company offers an extensive selection of products, including rings, earrings, bracelets, pendants, and necklaces crafted from materials such as silver, diamonds, colored gemstones, pearls, white gold, and yellow gold. Initially focused on diamond jewelry, Adamence has expanded its offerings to include various types of fine jewelry for both men and women. The company distinguishes itself by allowing customers to create personalized jewelry compositions, providing a bespoke shopping experience. With its control over goods and manufacturing, Adamence maintains competitive pricing while ensuring a wide product range for its clientele.

Anaconda Pharma

Series B in 2010
Anaconda Pharma is a privately held biopharmaceutical company founded in November 2003, located within the BioTop incubator at the Pasteur Institute campus in Paris, France. The company specializes in developing therapeutics aimed at treating infections caused by human papillomavirus (HPV), as well as related conditions such as condyloma. Through its research and development efforts, Anaconda Pharma seeks to address significant medical needs associated with HPV-related diseases.

Pharnext

Series A in 2010
Pharnext SA is a clinical-stage biopharmaceutical company based in Issy-Les-Moulineaux, France, focused on developing therapies for orphan and common neurodegenerative diseases. Founded in 2007 by prominent scientists including Professor Daniel Cohen, Pharnext employs a novel approach called PLEOTHERAPY, which utilizes advanced genomic data and network pharmacology to discover new uses for existing drugs. This process identifies synergistic combinations of approved medications, leading to the development of new therapeutics known as PLEODRUGS. Key products include SYNGILITY, which has completed Phase III trials for Charcot-Marie-Tooth disease type 1A, and PXT864, which has shown promise in Phase II trials for Alzheimer's disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Additionally, Pharnext collaborates with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential COVID-19 treatment. Through its innovative approach, Pharnext aims to provide effective and safe treatments for diseases with limited therapeutic options.

XenTech

Seed Round in 2008
XenTech SAS is a contract research organization based in Evry, France, specializing in preclinical oncology services. Founded in 2006, the company focuses on the evaluation of cancer drug efficacy through its innovative collection of patient-derived tumor xenografts. XenTech offers a range of services, including preclinical pharmacology studies, efficacy studies on human tumor xenografts, and various drug efficacy assays both in vivo and in vitro. Additionally, the organization provides preclinical consulting, tumor collection, and advanced imaging techniques such as real-time in vivo fluorescence and bioluminescence imaging. By leveraging its translational platforms, XenTech aims to support therapeutic development in oncology and help researchers address the evolving needs of preclinical cancer research.

Medelpharm

Venture Round in 2008
Medelpharm specializes in the manufacture of innovative powder compression devices aimed at research and development professionals across various industries, including pharmaceuticals, food, confectionary, chemistry, and batteries. With over 70 years of expertise in high precision engineering, the company focuses on the design and development of R&D tablet presses and related technologies. Medelpharm is committed to continuous innovation in powder compression while striving for excellence in collaboration with its clients. The company offers a comprehensive range of services, including powder compaction, flowability analysis, density measurement, in-die temperature control, and troubleshooting, thereby assisting customers in overcoming formulation and powder characterization challenges. Medelpharm's global team of skilled professionals in engineering and software development ensures complete and innovative solutions tailored to meet the needs of its customers.

EncherExpert

Venture Round in 2008
EncherExpert S.A.S., incorporated in 2005 and based in Paris, France, operates as an online shopping platform specializing in luxury goods. The company provides an e-commerce platform that facilitates the sale of decorative items and art objects, catering to a clientele interested in high-end products. EncherExpert combines online and in-store shopping experiences, enabling customers to access its offerings through multiple channels.

CoSpirit MediaTrack

Venture Round in 2007
CoSpirit MediaTrack is a marketing and communication consulting group that advises clients on the implementation and optimization of their campaigns.

Team Trade

Venture Round in 2007
Team Trade is a financial consultancy and IT services provider specifically focused on the financial markets. The company offers a range of services that include business consulting and software integration tailored for the financial services industry. By combining expertise in financial consultancy with advanced technology solutions, Team Trade helps clients navigate the complexities of the financial landscape, enhancing their operational efficiency and decision-making capabilities.

Sinequa

Series A in 2006
Sinequa SAS specializes in real-time big data search and analytics, catering to both companies and government agencies. Its flagship product, Sinequa ES, is a software platform that effectively integrates statistical analysis of structured data with linguistic and semantic analysis of textual data, enabling search and analytics across extensive and varied datasets. This platform serves a wide array of industries, including financial services, consumer products, government, telecommunications, manufacturing, professional services, media, and retail, as well as life sciences organizations. Sinequa also provides services such as consulting, project deployment, training, and ongoing support. The software can be deployed on-premise, in the cloud, or through hybrid installations. Founded in 1984 and based in Paris, France, Sinequa has additional offices in San Francisco, New York, London, and Frankfurt. The company has established strategic partnerships with organizations like Knowledgent and Atos, further enhancing its capabilities in delivering actionable insights to clients.

Conexance

Venture Round in 2006
Conexance is a database marketing company based in Lille, France, that specializes in direct marketing and the development of shared databases. The company has pioneered a shared database dedicated to distance selling and electronic commerce. Utilizing predictive models and machine learning, Conexance identifies statistical twins of customers, enabling clients to engage effectively across various channels. This approach enhances brands' understanding of their customer base and allows for targeted outreach based on actual purchasing behaviors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.